Treating hyperglycemia
Pro Research Analysisby 
Searched over 200M research papers for "treating hyperglycemia"
Treating Hyperglycemia: Current Approaches and Recommendations
Introduction to Hyperglycemia Management
Hyperglycemia, characterized by elevated blood glucose levels, is a common condition in individuals with diabetes and can lead to severe complications if not managed effectively. Recent research has provided updated guidelines and novel treatment options to improve patient outcomes.
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes
Cardiovascular and Renal Benefits
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have updated their recommendations to include the use of glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors for high-risk individuals. These medications are recommended to reduce major adverse cardiovascular events (MACE), hospitalization for heart failure (hHF), cardiovascular death, and chronic kidney disease (CKD) progression, regardless of baseline HbA1c levels 19.
Efficacy and Safety of SGLT2 Inhibitors
A systematic review and meta-analysis of randomized trials have shown that SGLT2 inhibitors, such as dapagliflozin, significantly reduce HbA1c, fasting plasma glucose, body mass index, and blood pressure. However, they also increase the risk of urinary and genital tract infections and mildly increase the risk of hypoglycemia when co-administered with insulin .
Hyperglycemia Management in Pregnancy
Early vs. Late Treatment
A randomized controlled trial investigated the effects of treating hyperglycemia in early pregnancy compared to the third trimester. The study found no significant differences in maternal or neonatal outcomes between the two groups, suggesting that early intensive treatment may not provide additional benefits over standard third-trimester treatment .
Inpatient Hyperglycemia Management
Non-Critical Care Settings
The Endocrine Society's clinical practice guideline emphasizes the importance of glycemic management in non-critically ill hospitalized patients. Recommendations include the use of continuous glucose monitoring, insulin pump therapy, and appropriate insulin regimens for prandial insulin dosing, glucocorticoid, and enteral nutrition-associated hyperglycemia .
Emergency Department Protocols
A study comparing an aspart insulin protocol in the emergency department (ED) with usual care found that the protocol significantly lowered blood glucose levels without prolonging ED length of stay. During hospitalization, a detemir-aspart protocol achieved better glycemic control compared to usual care, without increasing the risk of hypoglycemia .
Artificial Nutrition
Hyperglycemia is common in patients receiving enteral or parenteral nutrition. Intravenous continuous insulin infusion offers the best glycemic control, but subcutaneous insulin administration is also effective and less burdensome. Further research is needed to determine the optimal insulin regimen for these patients .
Traditional Herbal Medicine
Rhizoma Coptidis Alkaloids
Rhizoma Coptidis (RC) alkaloids have been used in traditional Chinese medicine to treat diabetes and hyperglycemia. Modern pharmacological studies have shown that these alkaloids balance glucose homeostasis by improving insulin resistance, promoting insulin secretion, regulating intestinal hormones, and ameliorating gut microbiota structures .
Conclusion
The management of hyperglycemia involves a multifaceted approach, including the use of novel medications like GLP-1 receptor agonists and SGLT2 inhibitors, tailored treatment protocols in hospital settings, and even traditional herbal remedies. Ongoing research and updated guidelines continue to refine these strategies to improve patient outcomes and reduce the risk of complications.
Sources and full results
Most relevant research papers on this topic
THE MANAGEMENT OF HYPERGLYCEMIA IN NONCRITICALLY ILL HOSPITALIZED PATIENTS TREATED WITH CONTINUOUS ENTERAL OR PARENTERAL NUTRITION.
Scheduled subcutaneous insulin is a safe and effective method to manage hyperglycemia in noncritically ill hospitalized patients receiving enteral or parenteral nutrition therapy.
DOI